000 01291 a2200361 4500
005 20250515005711.0
264 0 _c20051215
008 200512s 0 0 eng d
022 _a1389-4501
024 7 _a10.2174/138945005774574498
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStaehler, M
245 0 0 _aTargeted agents for the treatment of advanced renal cell carcinoma.
_h[electronic resource]
260 _bCurrent drug targets
_cNov 2005
300 _a835-46 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAngiogenesis Inhibitors
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBenzimidazoles
_xadministration & dosage
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aDrug Delivery Systems
650 0 4 _aHumans
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _avon Hippel-Lindau Disease
_xgenetics
700 1 _aRohrmann, K
700 1 _aHaseke, N
700 1 _aStief, C G
700 1 _aSiebels, M
773 0 _tCurrent drug targets
_gvol. 6
_gno. 7
_gp. 835-46
856 4 0 _uhttps://doi.org/10.2174/138945005774574498
_zAvailable from publisher's website
999 _c15928785
_d15928785